Exporter cette référence

VARSITY: a Double-Blind, Double-Dummy, Randomised, Controlled Trial of Vedolizumab Versus Adalimumab in Patients with Active Ulcerative Colitis Schreiber S, Peyrin-Biroulet L, Loftus Jr EV, et al (2019) ECCO, OP 34

Colon Rectum, 13 3 (2019) 163
DOI: https://doi.org/10.3166/cer-2019-0098